AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2004
Jul 16, 2004
29875_dirs_2004-07-16_d5425805-9849-4101-934f-bd88c7ea232f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: CVS CORP (CVS)
CIK: 0000064803
Period of Report: 2004-06-04
Reporting Person: GOLDSTEIN STANLEY P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-06-04 | Common Stock | M | 50000 | $16.1811 | Acquired | 354539 | Direct |
| 2004-06-04 | Common Stock | S | 50000 | $42.0757 | Disposed | 304539 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 40000 | Indirect |
| Common Stock | 10000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $16.1811 | 2005-04-11 | Common Stock (650000) | 650000 | Direct |
| Stock Option | $29.925 | 2012-01-02 | Common Stock (15000) | 15000 | Direct |
| Share Credits | $0 | Common Stock (9097) | 9097 | Direct |
Footnotes
F1: Amended Form is being submitted to correct previous typographical error.
F2: Cash exercise funded by Insider.
F3: Consists of Deferred Stock Compensation payable pursuant to Insider's election.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3